Entera Bio Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Entera Bio Ltd
Access all reports
Entera Bio Ltd. is a biotechnology company focused on the development of oral drug formulations for conditions traditionally treated with injectable therapies. The company specializes in proprietary oral delivery technology to improve the bioavailability of large molecules, such as peptides and proteins. Entera Bio’s research targets metabolic and endocrine disorders, including osteoporosis and hypoparathyroidism. The company is headquartered in Jerusalem, Israel, and its shares are listed on the NASDAQ.
Key slides for Entera Bio Ltd
Corporate Presentation
Entera Bio Ltd
Corporate Presentation
Entera Bio Ltd
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
ENTX
Country
🇺🇸 United States